for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Hemispherx Expands Ampligen Early Access Programme To Canada To Treat ME/CFS Patients

April 4 (Reuters) - Hemispherx Biopharma Inc:

* HEMISPHERX EXPANDS AMPLIGEN EARLY ACCESS PROGRAMME TO CANADA TO TREAT ME/CFS PATIENTS

* AMENDED TO INCLUDE MANAGEMENT OF A SAP IN CANADA FOR PATIENTS SUFFERING FROM MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME

* FIRST COMMERCIAL SIZE BATCH OF AMPLIGEN, WHICH WILL CONTAIN ABOUT 8,300 VIALS, IS ANTICIPATED TO BE AVAILABLE IN MAY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up